Black checkmark with a sparkle and a curved line underneath on a white background.
Company

DocGo Inc.

Ticker
DCGO
Sector
Industry
Report date
November 10, 2026
Valye AI Score

94

Very high visibility
Recent developments
Recent developments summary

Recent developments include DocGo’s Q3 2026 financial results reporting a net loss and revenue below expectations, alongside a CEO transition announcement.

Recent developments:
  • DocGo reported a net loss for Q3 2026 with revenue below prior expectations [N3].
  • The company announced a CEO transition concurrent with the release of Q3 2026 results [N2].
  • DocGo’s Q3 2026 earnings call provided detailed discussion of operational performance and strategic priorities [N1].
Overview

DocGo Inc. is a healthcare company delivering mobile health services, virtual care management, and medical transportation through its Ambulnz brand. The company’s vertically integrated platform enables healthcare delivery outside traditional facilities, combining virtual and in-person care to improve accessibility and reduce costs. DocGo serves municipalities, hospitals, insurers, and employers, with operations in all 50 U.S. states and the U.K. The business model includes partnerships with health plans for care gap closure and value-based reimbursement arrangements. DocGo’s Mobile Health Services and Transportation Services segments generated approximately 38% and 62% of revenues respectively in 2025. The company employs over 3,600 staff and maintains a proprietary technology platform integrated with major electronic medical record systems. Labor costs are significant, representing about 77% of revenues in 2025, with workforce availability and potential unionization noted as risks. Recent quarterly results show ongoing net losses and liquidity ratios suggest moderate short-term financial health.

Executive summary

DocGo Inc. operates a vertically integrated healthcare delivery platform combining mobile health services, virtual care management, and ambulance transportation across the U.S. and U.K. The company focuses on delivering accessible, patient-centered care outside traditional healthcare facilities, leveraging proprietary technology and a network of clinicians. As of September 30, 2026, DocGo reported $73.4 million in revenue and a net loss of $16.6 million for Q3 2026, with liquidity ratios indicating moderate short-term financial flexibility. Labor costs constitute the largest expense and remain a key operational challenge amid a competitive labor market. Recent news highlights a CEO transition and Q3 2026 financial results below revenue expectations. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.

Scenarios for DCGO

Bull case model:

DocGo’s integrated platform addresses growing demand for accessible, patient-centered healthcare outside traditional settings, combining virtual and in-person care. Its partnerships with major health plans and government entities provide a broad patient base and opportunities for value-based care arrangements. The company’s proprietary technology and extensive clinician network support operational efficiency and quality. High customer satisfaction scores and comprehensive employee training and incentive programs may enhance retention and service quality. The company’s ability to leverage technology to streamline transportation and mobile health services could improve cost efficiency and scalability.

Bear case model:

DocGo faces significant labor cost pressures, with labor expenses constituting the largest portion of revenues and challenges in recruiting and retaining qualified healthcare professionals amid a competitive labor market. Potential unionization activity could increase labor costs materially. The company reported ongoing net losses and revenue below expectations in recent quarters, indicating operational and financial challenges. Government contract revenue is declining as migrant-related programs wind down, reducing a previously substantial revenue source. Liquidity ratios suggest moderate short-term financial flexibility but highlight the need for careful cost management. Competition from fragmented providers offering point solutions may pressure pricing and margins.

Moat:

DocGo’s moat derives from its vertically integrated healthcare delivery platform combining mobile health services, virtual care management, and medical transportation, supported by proprietary technology integrated with major electronic medical record systems. The company’s extensive clinician network and partnerships with health plans covering over 60 million lives provide scale and access advantages. Its focus on care gap closure and value-based reimbursement models aligns incentives with improved patient outcomes and cost management. High customer satisfaction, as reflected in a Net Promoter Score of 92, and comprehensive training and incentive programs for clinicians contribute to operational quality and employee retention. The combination of technology, scale, and integrated services creates barriers to entry for competitors offering only point solutions.

Risks overview
Risks summary
Labor cost pressures and workforce availability pose the most significant risks to DocGo’s operational and financial performance.
Risks details:

• Labor Cost and Workforce Availability: Labor expenses represent approximately 77% of revenues, with challenges in recruiting and retaining qualified healthcare professionals in a competitive market. Potential unionization and wage increases could materially raise costs, adversely affecting financial results.
• Financial Performance and Liquidity: DocGo reported net losses in recent quarters with revenue below expectations. Liquidity ratios indicate moderate short-term financial flexibility, requiring ongoing management of costs and cash flow.
• Competitive Landscape: The healthcare delivery and medical transportation markets are fragmented with many competitors offering point solutions. Maintaining scale, technology integration, and service quality is critical to defend market position.
• Dependence on Government Contracts: Government contract revenue has declined due to wind-down of migrant-related programs, reducing a significant revenue source and impacting overall revenue composition.

FINAL FORECAST FOR DCGO

Final take one line
DocGo Inc. operates a vertically integrated mobile healthcare and transportation platform with detailed public disclosures, facing labor cost challenges and recent leadership changes.
Final take 12 to 24 month view

Business trends: Increasing integration of virtual and in-person mobile healthcare services with expanding health plan partnerships and focus on value-based care.
Execution milestones: Managing labor costs amid workforce challenges, navigating CEO transition, and maintaining technology platform enhancements.
Key risks: Labor cost inflation and workforce availability, ongoing net losses, competitive pressures, and reduced government contract revenues.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

94
LLM visibility overview
LLM Visibility known facts
  • DocGo Inc. operates a vertically integrated healthcare delivery platform including mobile health services, virtual care management, and ambulance services across all 50 U.S. states and the United Kingdom [S1].
  • The company’s business model focuses on delivering healthcare outside traditional facilities, combining virtual and in-person care to improve accessibility and reduce costs [S1].
  • DocGo’s Mobile Health Services segment provides on-site evaluation, diagnostics, triage, and treatment, addressing over 50 care gaps for health plans, especially Medicare Advantage, Managed Medicaid, and Marketplace plans [S1].
  • DocGo’s Transportation Services segment operates under the Ambulnz brand, providing medical transportation with a fleet equipped with proprietary technology integrated with major electronic medical record systems [S1].
  • As of December 31, 2025, DocGo employed approximately 3,600 employees including healthcare professionals, field management, and corporate support staff, with additional subcontracted and independent contractors [S1].
  • Labor costs represent the largest expense, approximately 77% of 2025 revenues, with challenges in recruiting and retaining qualified healthcare professionals in a competitive labor market [S2].
  • DocGo’s liquidity as of September 30, 2026, includes $19.1 million in cash and equivalents, current assets of $109.7 million, current liabilities of $79.7 million, resulting in a current ratio of 1.38 and a cash ratio of 0.24 [S2].
  • For the quarter ended September 30, 2026, DocGo reported revenue of approximately $73.4 million and a net loss of about $16.6 million, with basic and diluted EPS of -$0.17 [S2].
  • DocGo’s mobile health model has facilitated over 10 million patient interactions since inception, with over 1.3 million patient interactions in recent periods and a network of more than 900 medical clinicians [S1].
  • The company has active partnerships with multiple health plans covering over 60 million lives, focusing on care gap closure and value-based reimbursement models involving graduated risk-sharing arrangements [S1].
  • DocGo’s government contract work represented a declining portion of revenue, approximately 38% in 2025, down from higher percentages in prior years, due to wind-down of migrant-related programs [S1].
  • DocGo’s Mobile Health Services segment generated about 38% of revenues and Transportation Services about 62% for the fiscal year ended December 31, 2025 [S1].
  • DocGo’s Net Promoter Score for Mobile Health Services was 92 for the year ended December 31, 2025, indicating high customer satisfaction [S1].
  • Recent news reports indicate DocGo reported a Q3 2026 loss and revenue below expectations, and announced a CEO transition [N2][N3].
  • DocGo’s labor costs and workforce availability remain significant operational challenges, with potential unionization activity noted as a risk factor [S2].
  • DocGo offers an equity incentive plan for frontline clinicians and comprehensive training programs to attract and retain talent [S1].
  • DocGo’s proprietary technology platform aims to improve efficiency in patient transportation and mobile health services, integrating with healthcare providers’ systems [S1].
  • DocGo’s business combination with Ambulnz in 2021 created the current company structure [S1].
  • Financial figures are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice [S2].
Sources
Sources - Context summary

Generated 2026-11-10

Sources - Earning calls
  • N1
Sources - Other context
  • S1
  • S2
Sources - SEC Filings
  • S1 | 2026-03-16 | 10-K
  • S2 | 2026-11-09 | 10-Q
Sources - News headlines
  • N1 | 2026-11-10 | www.nasdaq.com | DocGo (DCGO) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/docgo-dcgo-q3-2026-earnings-call-transcript
  • N2 | 2026-11-10 | www.nasdaq.com | DocGo Inc. Announces Third Quarter 2026 Results and CEO Transition | https://www.nasdaq.com/articles/docgo-inc-announces-third-quarter-2026-results-and-ceo-transition
  • N3 | 2026-11-09 | www.nasdaq.com | DocGo Inc. (DCGO) Reports Q3 Loss, Lags Revenue Estimates | https://www.nasdaq.com/articles/docgo-inc-dcgo-reports-q3-loss-lags-revenue-estimates
  • N4 | 2026-11-06 | www.nasdaq.com | Shoulder Innovations, Inc. (SI) Reports Q3 Loss, Misses Revenue Estimates | https://www.nasdaq.com/articles/shoulder-innovations-inc-si-reports-q3-loss-misses-revenue-estimates
  • N5 | 2026-10-30 | www.nasdaq.com | Organon (OGN) Q3 Earnings and Revenues Top Estimates | https://www.nasdaq.com/articles/organon-ogn-q3-earnings-and-revenues-top-estimates
  • N6 | 2026-08-18 | www.nasdaq.com | DocGo Inc. Q2 Loss Widens | https://www.nasdaq.com/articles/docgo-inc-q2-loss-widens
  • N7 | 2026-08-17 | www.nasdaq.com | DocGo Q2 Earnings Call Highlights | https://www.nasdaq.com/articles/docgo-q2-earnings-call-highlights
  • N8 | 2026-08-17 | www.nasdaq.com | DocGo Inc. (DCGO) Surpasses Q2 Earnings Estimates | https://www.nasdaq.com/articles/docgo-inc-dcgo-surpasses-q2-earnings-estimates
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine